 Without treatment, this results in developmental decline and muscle weakness, eventually leading to severe retardation and death.Antibodies to GM1 are increased in Guillain–Barré syndrome, dementia and lupus but their function is not clear.There is some evidence to suggest antibodies against GM1 are associated with diarrhea in Guillain–Barré syndrome.